News Conference News ACC 2016 Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why Yael L. Maxwell April 06, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ACC 2016 Discrimination Still Runs Rampant for Women in Cardiology Yael L. Maxwell April 02, 2016
News Conference News ACC 2015 DANAMI3-PRIMULTI: Complete Revascularization Improves Outcomes for STEMI Yael L. Maxwell March 17, 2015
News Conference News ACC 2015 ERICCA: Remote Ischemic Preconditioning Fails to Improve Long-Term Outcomes After CABG Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Fellows-Focused Session Emphasizes Best Practices for Building a Career in Cardiology Yael L. Maxwell March 14, 2015
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2014 Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure Yael L. Maxwell March 31, 2014
News Conference News ACC 2014 Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted Yael L. Maxwell March 30, 2014
News Conference News ACC 2014 Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation Yael L. Maxwell March 30, 2014
News Conference News ACC 2014 TAVR With the CoreValve Device Superior to Surgery at 1 Year Yael L. Maxwell March 29, 2014
News Conference News ACC 2014 Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure Yael L. Maxwell March 29, 2014
News Conference News ACC 2013 PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 Coronary CTA Predictive, Resource-Saving When Used in Emergency Department Yael L. Maxwell March 11, 2013
News Conference News ACC 2013 STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital Yael L. Maxwell March 09, 2013